Company Analysis

Shattuck Labs, Inc. (STTK)

Nasdaq: STTK · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2016
Grade4.8
◀ Past 4.9● Present 5.3▶ Future 4.4
1 est.

The grade of Shattuck Labs, Inc.

Nine metrics read from its own filings, by tense
Headline grade
4.8/10
◀ Past4.925% of the headline
● Present5.335% of the headline
▶ Future4.440% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

4.9/1025% of the headline grade · 2 of 3 filed, 1 estimated

Surviving crises

as filed
8.2/10

Has it survived what it has been through?

No warning events in its filings since 2017.

weight 22% of this tense · 82nd percentile among 497 sector filers · read for itself

From the record

Shattuck Labs, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
3.0/10

What has it actually done, year after year?

-31.7% a year over 7 filed years; profitable in 0 of 7.

weight 45% of this tense · 30th percentile among 323 sector filers · read for its customers

From the record

Shattuck Labs, Inc.'s 7 filed years say what it did: revenue went from $10 million in fiscal 2019 to $1 million in fiscal 2025, down 31.7% a year; it rose in 4 of 6 years; the deepest fall was 98% from fiscal 2021 to fiscal 2022; net income was positive in 0 of 7 of those years (its annual reports).

What it rests on

  • revenue growth over the filed span-31.7%bottom 9% of its family
  • the share of years revenue rosetop 41% of its family
  • the share of filed years with a profitbottom 27% of its family
  • the deepest fall from a revenue peak97.8%bottom 26% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

SI estimate
5.2/10

How has it treated the people who own it?

SI estimate 5.2/10, confidence 35 of 100 (one part).

weight 33% of this tense · 52nd percentile among 464 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, the share count over the years, which ranks in the top 48% of 464 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read
Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned
one part: the share count over the years, the one part on file, ranked among 464 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Shattuck Labs, Inc.'s shareholder treatment is put at 5.2 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the top 48% of 464 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

5.3/1035% of the headline grade · 3 of 3 filed

Financial health

as filed
5.6/10

Is it financially healthy right now?

ROE -59%: lost 59¢ per shareholder dollar. Leverage 9%: owes 9¢ per asset dollar.

weight 45% of this tense · 56th percentile among 473 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Shattuck Labs, Inc. lost about 59 cents for every dollar of shareholders' money. Leverage: it owed about 9 cents per dollar of assets, and net share issuance: its share count grew 37.1% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetstop 15% of its family
  • return on equitybottom 45% of its family
  • the share count against the year beforebottom 38% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
3.2/10

How strong is its position in its industry?

bottom 32% of 315 in its family; net margin -4880.9%.

weight 22% of this tense · 32nd percentile among 315 sector filers · read for its customers

From the record

Shattuck Labs, Inc.'s standing among 315 graded names in its industry family: revenue of $1 million in fiscal 2025 ranks in the bottom 22% by size; a net margin of -4880.9% ranks in the bottom 16%; revenue growth of 15.3% a year over the last 3 filed years ranks in the top 42% (its annual reports).

What it rests on

  • revenue against the family$1.0Mbottom 22% of its family
  • net margin-4880.9%bottom 16% of its family
  • three-year revenue growth15.3%top 42% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

as filed
6.4/10

What are the people in charge doing?

top 36% of 315 in its family for leadership; chief executive since 2020.

weight 33% of this tense · 64th percentile among 315 sector filers · read for its shareholders

From the record

Shattuck Labs, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Schreiber, Taylor (Chief Executive Officer, as filed), filing under that title since 2020-10-08, 6.1 years (top 39% of its family); the 13 officers and directors filing in the last fifteen months have been on the record a median of 6.1 years (top 39%); 4 officer or director changes were reported on Form 8-K since 2023-11-13, against the 13 people in charge now (top 30%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

What it rests on

  • officer and director changes on Form 8-K, against the people in charge4 in three years among 13 peopletop 30% of its family
  • the median years the people in charge have filed6.1 yearstop 39% of its family
  • the chief executive's years on the record6.1 yearstop 39% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

▶ Future

What are they set up to do next?

4.4/1040% of the headline grade · 3 of 3 filed

Room to expand

as filed
5.8/10

How much room does it have to grow?

top 42% of 273 in its family for room to expand.

weight 33% of this tense · 58th percentile among 273 sector filers · read for itself

From the record

Shattuck Labs, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $54 million against no long-term debt tagged leaves 59.5% of its assets as net cash, top 27% of its family; cash from operations less capital spending is -3995.3% of revenue (bottom 13%); research spending of 3527.3% of revenue (top 12%) (its annual report).

What it rests on

  • cash less debt against assets59.5%top 27% of its family
  • cash from operations less capital spending against revenue-3995.3%bottom 13% of its family
  • research spending against revenue3527.3%top 12% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
2.9/10

What could actually drive growth from here?

bottom 29% of 306 in its family for growth drivers.

weight 45% of this tense · 29th percentile among 306 sector filers · read for its customers

From the record

Shattuck Labs, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 15.3% a year over the last three filed years against -31.7% over all 7, speeding up (top 10% of its family); the newest year grew -82.5% (bottom 6%); research spending grew -24.8% a year (bottom 16%); capital spending grew -81.7% a year (bottom 2%) (its annual reports). Shattuck Labs, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

What it rests on

  • three-year growth against the whole span+47.1 points a yeartop 10% of its family
  • the newest year's revenue growth-82.5%bottom 6% of its family
  • three-year growth of research spending-24.8%bottom 16% of its family
  • three-year growth of capital spending-81.7%bottom 2% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed
5.3/10

Did its newest year beat what its own record pointed to?

top 47% of 233 in its family for expectations against reality.

weight 22% of this tense · 53rd percentile among 233 sector filers · read for its shareholders

From the record

Shattuck Labs, Inc.'s newest year against its own record: revenue of $1 million in fiscal 2025 came in 94.1% below the $17 million its prior three years' pace pointed to (bottom 5% of its family); net income of $49 million against a prior three-year average of $88 million (top 35%); a net margin of a loss larger than its revenue against losses larger than its revenue before (top 11%) (its annual reports).

What it rests on

  • revenue against the prior three years' pace-94.1%bottom 5% of its family
  • net income against the prior three years' average+45%top 35% of its family
  • net margin against its prior averageup more than 100 pointstop 11% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton STTK · research, not advice